Welcome to the Research & Development (R&D) Department webpage. The R&D Department is dedicated to supporting research and is responsible for ensuring that all research conducted in the Trust conforms to all necessary legal, regulatory and ethical requirements. The Trust is committed to delivering a research agenda which is responsive to national guidance for clinical and cost-effectiveness and for systematic measures to monitor and improve quality.
Research affects us all; many of the technologies and therapies that we associate with the delivery of a modern health service have their origin in research. Therefore, research is essential to developing the evidence base for the successful promotion and protection of health and well-being and to modern and effective health and social services.
By its very nature, research can involve an element of risk, both in terms of return on investment and sometimes for the safety and well-being of research participants. Therefore appropriate governance of research is essential to ensure that the public can have confidence in, and benefit from, quality research in health and community care.
The research department supports on average 50-70 active research studies during a typical year, most of which are adopted by the National Institute for Health Research Clinical Research Network. Tameside and Glossop Integrated Care NHS Foundation Trust is a host organisation for the Clinical Research Network: Greater Manchester. All studies the Trust supports have received a favourable opinion from the National Research Ethics Service and the Health Research Authority, where appropriate.
The R&D Department at Tameside General Hospital has an approval process in place in line with the UK policy framework for health and social care research.. All research conducted within Tameside General Hospital must be registered with, and receive confirmation of capacity and capability by the Trust's R&D Department prior to any research activity commencing. Investigators are encouraged to contact the R&D Department ASAP to register projects and obtain a unique study reference number. Staff are asked to submit their IRAS applications and protocol to start the approval process. The Department also facilitates the R&D process by issuing Letters of Access, contract negotiation and ensuring staff have attended a Good Clinical Practice (GCP) training session.
Patient information and health and care research
As a NHS organisation we use personally-identifiable information to conduct research to improve health, care and services. As a publicly-funded organisation, we have to ensure that it is in the public interest when we use personally-identifiable information from people who have agreed to take part in research. This means that when you agree to take part in a research study, we will use your data in the ways needed to conduct and analyse the research study. Your rights to access, change or move your information are limited, as we need to manage your information in specific ways in order for the research to be reliable and accurate. If you withdraw from the study, we will keep the information about you that we have already obtained. To safeguard your rights, we will use the minimum personally-identifiable information possible.
Health and care research should serve the public interest, which means that we have to demonstrate that our research serves the interests of society as a whole. We do this by following the UK Policy framework for health and social care research.
If you wish to raise a complaint on how we have handled your personal data, you can contact our Patient Advice and Liaison service who will investigate the matter. If you are not satisfied with our response or believe we are processing your personal data in a way that is not lawful you can complain to the Information Commissioner’s Office (ICO).
Our Patient Advice and Liaison Service can be contacted on 0161 922 4466 or email email@example.com
For more information on the use of patient information in research, please see https://www.hra.nhs.uk/information-about-patients/ or go to ‘How we use patient information’ on the Trusts homepage.
The Research Department works under the management of the Medical Director, Mr Brendan Ryan, who is also the Director of R&D and the Chair of the Research and Development Committee.
Mr Brendan Ryan Medical Director and Director of Research and Development 0161 922 6006
Mrs Margaret Cooper Associate Director of Research and Innovation 0161 922 4011
Mrs Rebecca Roberts Research and Governance Manager 0161 922 4451
Address: Research Office, 3rd Floor Charlesworth Building, Tameside Hospital NHS Foundation Trust, Fountain Street, Ashton Under Lyne, OL6 9RW.
Research Nurses and support staff
Stephanie Ridgway Senior Oncology Research Nurse 0161 922 4011
Joanne Vere Oncology and Generic Research Nurse 0161 922 4078
Wendy Hulse Paediatric Research Nurse 0161 922 5058
Jane McConniffe Rheumatology Research Nurse 0161 922 4078
Martina Coulding Oncology Clinical Trials Administrator 0161 922 4011
Martyn Clarke Oncology Administrative Assistant 0161 922 4011
Heather Savil Research Nurse 0161 922 4078
Jacqueline McCormick Research Nurse 0161 922 4078
Tameside Hospital has an increasing Research portfolio. We have strong research activity in our Oncology department and more clinicians and departments are becoming research active each year. Below is a list of current research active departments. For further information relating to clinicians involved in research and specific studies, please contact the Research office.
Research Active Departments
Orthodontics Lower GI/Colorectal
Upper GI Obstetrics & Gynaecology
International Clinical Trials Day
International Clinical Trials Day is celebrated around the world on or near the 20 May each year, to commemorate the day that James Lind started his famous trial on the deadly disease scurvy. It provides a focal point to raise awareness of the importance of research to health care, and highlights how partnerships between patients and healthcare practitioners are vital to high-quality, relevant research.
On International Clincial Trials Day, the National Institute for Health Research (NIHR) promotes its "OK to ask" campaign to encourage patients and the public to ask medical professional about clinical research.
It’s ‘OK to ask’ Campaign
OK to ask aims to encourage more patients or carers to ask about research opportunities that could be available to them or their loved ones, if they have a medical condition they are receiving treatment for. That essentially it is “OK to ask” about research opportunities.
A recent survey conducted by the NIHR Clinical Research Network showed that 95% of people surveyed said it was important to them that the NHS carries out clinical research but less than 21% said they would feel very confident about asking their doctor about research opportunities.
That is why Tameside Hospital is supporting NIHR campaign to promote the fact that it’s OK to ask about clinical research.
Whilst the campaign is primarily aimed at encouraging more patients to ask about research opportunities, it’s also about reminding all healthcare professionals from consultants and GP’s to nurses and midwives, whether research-active or not, to be research-aware.
Standard Operating Procedures
The Trust Research and Development Department have a number of Standard Operating Procedures (SOPs), which must be complied with during the conduct of a clinical Trial. There are also a number of supporting department policies that are relevant to research, which also must be followed. For further information on Research SOP's and policies, please contact the R&D Office on extention 4451, firstname.lastname@example.org. Research SOPs are available on the Trusts Research and Development departmental site on the intranet and on request from the research office. Printed controlled copies of all SOPs will be available in the Trust’s Library in the near future
Research Patient Information Leaflet
A research Patient Information Leaflet has been created and approved by the Research and Development committee. The leaflet can be found in the Trusts Health Information Centre, Hartshead North and under the Patient Information Leaflet section on the Intranet. For a copy of the Research Patient information Leaflet please click here.
Performance information on the initiation and delivery of clinical research
NIHR Clinical Trial 70-day Benchmark and Clinical Trial Recruitment Transparency
The Government wants to see a dramatic and sustained improvement in the performance of providers of NHS services in initiating and delivering clinical research.
The Government’s Plan for Growth, published in March 2011, announced the transformation of incentives at local level for efficiency in initiation and delivery of clinical research.
As part of this incentivisation, the Department of Health requires, via the new National Institute for Health Research (NIHR) contracts with providers of NHS services, the publication on a quarterly basis of information regarding: the 70-day benchmark for clinical trial initiation; and the recruitment to time and target for commercial contract clinical trials.
Providers of NHS services are required to publish the following information for Initiating Clinical Research (i.e. the 70-day benchmark) on a publicly available part of their website:
Providers of NHS services are also required to publish the following information regarding commercial contract clinical trials, to meet the transparency commitment for delivering clinical research to time and target on a publicly available part of their website:
Performance in Initiating Clinical research
|2015/16 Quarter 2||Performance in Initiating|
|2015/16 Quarter 3||Performance in Initiating|
2015/16 Quarter 4 Performance in Initiating
Performance in Delivering clinical research
2014/15 Quarter 3
2014/15 Quarter 4
2015/16 Quarter 2
|Performance in Delivery|
|2015/16 Quarter 3||Performance in Delivery|
|2015/16 Quarter 4||Performance Delivery|
|2016/17 Quarter 1||Performance Delivery|
|2016/17 Quarter 1||Performance in Initiating|
2016/17 Quarter 2
2016/17 Quarter 2
|Performance in Initiating|
|2016/17 Quarter 3||Performance in Delivery|
|2016/17 Quarter 3||Performance in Initiating|
|2016/17 Quarter 4||Performance in Delivery|
|2016/17 Quarter 2||Performance in Initiating|
|2017/18 Quarter 1||Performance in Delivery|
|2017/18 Quarter 1||Performance in Initiating|
|2017/18 Quarter 2||Performance in Delivery|
|2017/18 Quarter 3|
|2017/18 Quarter 3|
|2017/18 Quarter 4|
|2017/18 Quarter 4|
|2018/19 Quarter 1||Performance in Initiating|
|2018/19 Quarter 1||Performance in Delivery|
|2018/19 Quarter 2||Performance in Initiating|
|2018/19 Quarter 2||Performance in Delivery|
|2018/19 Quarter 3||Performance in Initiating|
|2018/19 Quarter 3||Performance in Delivery|
|2018/19 Quarter 4||Performance in Initiating|
|2018/19 Quarter 4||Performance in Delivery|